From the outset, Kamala Harris’s presidential campaign has been notorious for being almost completely policy-free. Most of the policy positions that were belatedly added to her website a few weeks ago are copied, in some cases nearly verbatim, from Joe Biden’s site. Others, such as no taxes on tips, were shamelessly cribbed from Donald Trump. Simultaneously, Harris has sought to distance herself from the positions she took during her 2020 presidential run, on everything from criminal-justice reform, to immigration, guns, healthcare, fracking, and transgender care (often without clarifying what her current stance is). And like her current boss, Harris has also largely avoided media interviews and other unscripted events.
Consequently, it’s hard to tell how a Harris-Walz White House might differ, if at all, from the incumbent Biden-Harris administration. This seems to be no accident. The vice president is evidently hoping that she can just ride into the White House based on vague but positive messaging and public disdain for Trump, and then let folks figure out her agenda—and perhaps, figure it out herself—after she is in office.
All of this was on display in one of her few interviews, when Harris was asked what she would do to lower prescription drug prices. She answered: